nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabrafenib—ABCG2—gout	0.391	1	CbGaD
Dabrafenib—SLC22A8—Allopurinol—gout	0.0745	0.172	CbGbCtD
Dabrafenib—SLCO1B1—Indomethacin—gout	0.0356	0.0822	CbGbCtD
Dabrafenib—SLC22A6—Naproxen—gout	0.0346	0.08	CbGbCtD
Dabrafenib—SLC22A8—Probenecid—gout	0.0337	0.078	CbGbCtD
Dabrafenib—SLC22A8—Indomethacin—gout	0.0328	0.0759	CbGbCtD
Dabrafenib—SLC22A6—Probenecid—gout	0.0235	0.0543	CbGbCtD
Dabrafenib—SLC22A6—Indomethacin—gout	0.0229	0.0529	CbGbCtD
Dabrafenib—CYP2C8—Naproxen—gout	0.0228	0.0527	CbGbCtD
Dabrafenib—ABCG2—Hydrocortisone—gout	0.0174	0.0403	CbGbCtD
Dabrafenib—CYP2C8—Colchicine—gout	0.0173	0.0399	CbGbCtD
Dabrafenib—CYP2C8—Probenecid—gout	0.0155	0.0357	CbGbCtD
Dabrafenib—ABCB1—Colchicine—gout	0.0117	0.027	CbGbCtD
Dabrafenib—ABCB1—Probenecid—gout	0.0105	0.0242	CbGbCtD
Dabrafenib—ABCB1—Methylprednisolone—gout	0.0103	0.0239	CbGbCtD
Dabrafenib—ABCB1—Indomethacin—gout	0.0102	0.0236	CbGbCtD
Dabrafenib—SLC22A8—Organic anion transport—SLC22A11—gout	0.00991	0.134	CbGpPWpGaD
Dabrafenib—CYP2C8—Hydrocortisone—gout	0.00928	0.0214	CbGbCtD
Dabrafenib—SLC22A6—Organic anion transport—SLC22A11—gout	0.00827	0.112	CbGpPWpGaD
Dabrafenib—SLC22A8—Organic anion transport—SLC22A12—gout	0.00751	0.102	CbGpPWpGaD
Dabrafenib—CYP3A4—Colchicine—gout	0.007	0.0162	CbGbCtD
Dabrafenib—ABCB1—Prednisolone—gout	0.00662	0.0153	CbGbCtD
Dabrafenib—ABCB1—Hydrocortisone—gout	0.00628	0.0145	CbGbCtD
Dabrafenib—CYP3A4—Probenecid—gout	0.00627	0.0145	CbGbCtD
Dabrafenib—SLC22A6—Organic anion transport—SLC22A12—gout	0.00627	0.0848	CbGpPWpGaD
Dabrafenib—ABCB1—Prednisone—gout	0.00625	0.0145	CbGbCtD
Dabrafenib—CYP3A4—Methylprednisolone—gout	0.00619	0.0143	CbGbCtD
Dabrafenib—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A11—gout	0.00461	0.0624	CbGpPWpGaD
Dabrafenib—CYP3A4—Prednisolone—gout	0.00397	0.00917	CbGbCtD
Dabrafenib—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A11—gout	0.00385	0.0521	CbGpPWpGaD
Dabrafenib—CYP3A4—Hydrocortisone—gout	0.00376	0.0087	CbGbCtD
Dabrafenib—CYP3A4—Prednisone—gout	0.00375	0.00866	CbGbCtD
Dabrafenib—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A12—gout	0.0035	0.0473	CbGpPWpGaD
Dabrafenib—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A12—gout	0.00292	0.0395	CbGpPWpGaD
Dabrafenib—ABCB1—Abacavir transmembrane transport—ABCG2—gout	0.00139	0.0189	CbGpPWpGaD
Dabrafenib—SLCO1B1—Irinotecan Pathway—ABCG2—gout	0.00122	0.0165	CbGpPWpGaD
Dabrafenib—RAF1—Stimuli-sensing channels—SLC17A3—gout	0.000929	0.0126	CbGpPWpGaD
Dabrafenib—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A11—gout	0.000924	0.0125	CbGpPWpGaD
Dabrafenib—ABCB1—Abacavir transport and metabolism—ABCG2—gout	0.000801	0.0108	CbGpPWpGaD
Dabrafenib—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A11—gout	0.000771	0.0104	CbGpPWpGaD
Dabrafenib—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—gout	0.0007	0.00948	CbGpPWpGaD
Dabrafenib—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—gout	0.000651	0.00881	CbGpPWpGaD
Dabrafenib—RAF1—Ion channel transport—SLC17A3—gout	0.000606	0.0082	CbGpPWpGaD
Dabrafenib—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—gout	0.000585	0.00791	CbGpPWpGaD
Dabrafenib—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—gout	0.000543	0.00735	CbGpPWpGaD
Dabrafenib—SLCO1B3—SLC-mediated transmembrane transport—SLC17A1—gout	0.000475	0.00642	CbGpPWpGaD
Dabrafenib—SLCO1B3—SLC-mediated transmembrane transport—SLC22A11—gout	0.000475	0.00642	CbGpPWpGaD
Dabrafenib—SLC22A8—SLC-mediated transmembrane transport—SLC17A1—gout	0.00042	0.00568	CbGpPWpGaD
Dabrafenib—SLC22A8—SLC-mediated transmembrane transport—SLC22A11—gout	0.00042	0.00568	CbGpPWpGaD
Dabrafenib—CYP3A4—Irinotecan Pathway—ABCG2—gout	0.000377	0.0051	CbGpPWpGaD
Dabrafenib—SLCO1B3—SLC-mediated transmembrane transport—SLC22A12—gout	0.00036	0.00487	CbGpPWpGaD
Dabrafenib—SLC22A6—SLC-mediated transmembrane transport—SLC22A11—gout	0.000351	0.00474	CbGpPWpGaD
Dabrafenib—SLC22A6—SLC-mediated transmembrane transport—SLC17A1—gout	0.000351	0.00474	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—NLRP3—gout	0.000343	0.00464	CbGpPWpGaD
Dabrafenib—SLCO1B3—SLC-mediated transmembrane transport—SLC2A9—gout	0.000334	0.00452	CbGpPWpGaD
Dabrafenib—SLCO1B1—SLC-mediated transmembrane transport—SLC17A1—gout	0.000319	0.00431	CbGpPWpGaD
Dabrafenib—SLCO1B1—SLC-mediated transmembrane transport—SLC22A11—gout	0.000319	0.00431	CbGpPWpGaD
Dabrafenib—SLC22A8—SLC-mediated transmembrane transport—SLC22A12—gout	0.000318	0.00431	CbGpPWpGaD
Dabrafenib—SLC22A8—SLC-mediated transmembrane transport—SLC2A9—gout	0.000296	0.004	CbGpPWpGaD
Dabrafenib—SLCO1B3—Transmembrane transport of small molecules—SLC17A3—gout	0.000296	0.004	CbGpPWpGaD
Dabrafenib—RAF1—Leptin signaling pathway—IL1RN—gout	0.000287	0.00388	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—LRRC16A—gout	0.000287	0.00388	CbGpPWpGaD
Dabrafenib—SLC22A6—SLC-mediated transmembrane transport—SLC22A12—gout	0.000266	0.00359	CbGpPWpGaD
Dabrafenib—SLC22A8—Transmembrane transport of small molecules—SLC17A3—gout	0.000262	0.00354	CbGpPWpGaD
Dabrafenib—SLC22A6—SLC-mediated transmembrane transport—SLC2A9—gout	0.000247	0.00334	CbGpPWpGaD
Dabrafenib—SLCO1B1—SLC-mediated transmembrane transport—SLC22A12—gout	0.000242	0.00327	CbGpPWpGaD
Dabrafenib—SLCO1B3—Transmembrane transport of small molecules—SLC17A1—gout	0.000241	0.00326	CbGpPWpGaD
Dabrafenib—SLCO1B3—Transmembrane transport of small molecules—SLC22A11—gout	0.000241	0.00326	CbGpPWpGaD
Dabrafenib—SLCO1B1—SLC-mediated transmembrane transport—SLC2A9—gout	0.000225	0.00304	CbGpPWpGaD
Dabrafenib—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—gout	0.000225	0.00304	CbGpPWpGaD
Dabrafenib—BRAF—MAPK Signaling Pathway—CASP1—gout	0.000224	0.00304	CbGpPWpGaD
Dabrafenib—Malnutrition—Naproxen—gout	0.000222	0.00217	CcSEcCtD
Dabrafenib—RAF1—Signaling by Interleukins—CASP1—gout	0.000221	0.00299	CbGpPWpGaD
Dabrafenib—Hyperhidrosis—Indomethacin—gout	0.000221	0.00217	CcSEcCtD
Dabrafenib—Hypertension—Allopurinol—gout	0.00022	0.00215	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Colchicine—gout	0.000219	0.00215	CcSEcCtD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—SLC17A3—gout	0.000219	0.00296	CbGpPWpGaD
Dabrafenib—Arthralgia—Allopurinol—gout	0.000216	0.00212	CcSEcCtD
Dabrafenib—Myalgia—Allopurinol—gout	0.000216	0.00212	CcSEcCtD
Dabrafenib—Cardiac failure congestive—Prednisolone—gout	0.000216	0.00211	CcSEcCtD
Dabrafenib—Unspecified disorder of skin and subcutaneous tissue—Allopurinol—gout	0.000215	0.00211	CcSEcCtD
Dabrafenib—RAF1—Signaling by Interleukins—IL1RN—gout	0.000214	0.0029	CbGpPWpGaD
Dabrafenib—Hypotension—Indomethacin—gout	0.000214	0.00209	CcSEcCtD
Dabrafenib—Muscle spasms—Naproxen—gout	0.000213	0.00209	CcSEcCtD
Dabrafenib—SLC22A8—Transmembrane transport of small molecules—SLC17A1—gout	0.000213	0.00289	CbGpPWpGaD
Dabrafenib—SLC22A8—Transmembrane transport of small molecules—SLC22A11—gout	0.000213	0.00289	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—SLC17A3—gout	0.000211	0.00285	CbGpPWpGaD
Dabrafenib—Cardiac failure congestive—Hydrocortisone—gout	0.000211	0.00207	CcSEcCtD
Dabrafenib—Decreased appetite—Colchicine—gout	0.000209	0.00205	CcSEcCtD
Dabrafenib—Vision blurred—Naproxen—gout	0.000209	0.00205	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Colchicine—gout	0.000208	0.00204	CcSEcCtD
Dabrafenib—Oedema—Allopurinol—gout	0.000208	0.00203	CcSEcCtD
Dabrafenib—Fatigue—Colchicine—gout	0.000208	0.00203	CcSEcCtD
Dabrafenib—Insomnia—Indomethacin—gout	0.000207	0.00203	CcSEcCtD
Dabrafenib—Blood alkaline phosphatase increased—Methylprednisolone—gout	0.000207	0.00202	CcSEcCtD
Dabrafenib—Infection—Allopurinol—gout	0.000206	0.00202	CcSEcCtD
Dabrafenib—Anaemia—Naproxen—gout	0.000205	0.00201	CcSEcCtD
Dabrafenib—Dermatitis bullous—Prednisolone—gout	0.000205	0.00201	CcSEcCtD
Dabrafenib—Nervous system disorder—Allopurinol—gout	0.000203	0.00199	CcSEcCtD
Dabrafenib—Thrombocytopenia—Allopurinol—gout	0.000203	0.00199	CcSEcCtD
Dabrafenib—Skin disorder—Allopurinol—gout	0.000202	0.00197	CcSEcCtD
Dabrafenib—Hyperhidrosis—Allopurinol—gout	0.000201	0.00197	CcSEcCtD
Dabrafenib—LIMK1—Immune System—NLRP3—gout	0.0002	0.0027	CbGpPWpGaD
Dabrafenib—Decreased appetite—Indomethacin—gout	0.000199	0.00195	CcSEcCtD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—SLC17A3—gout	0.000199	0.00269	CbGpPWpGaD
Dabrafenib—Leukopenia—Naproxen—gout	0.000199	0.00195	CcSEcCtD
Dabrafenib—Cardiac failure congestive—Methylprednisolone—gout	0.000198	0.00194	CcSEcCtD
Dabrafenib—Fatigue—Indomethacin—gout	0.000197	0.00193	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Colchicine—gout	0.000197	0.00193	CcSEcCtD
Dabrafenib—Constipation—Indomethacin—gout	0.000196	0.00192	CcSEcCtD
Dabrafenib—Hypotension—Allopurinol—gout	0.000194	0.0019	CcSEcCtD
Dabrafenib—Cough—Naproxen—gout	0.000194	0.0019	CcSEcCtD
Dabrafenib—Hypertension—Naproxen—gout	0.000192	0.00188	CcSEcCtD
Dabrafenib—Abdominal pain—Colchicine—gout	0.00019	0.00186	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Allopurinol—gout	0.000189	0.00185	CcSEcCtD
Dabrafenib—Arthralgia—Naproxen—gout	0.000189	0.00185	CcSEcCtD
Dabrafenib—Myalgia—Naproxen—gout	0.000189	0.00185	CcSEcCtD
Dabrafenib—Unspecified disorder of skin and subcutaneous tissue—Naproxen—gout	0.000188	0.00184	CcSEcCtD
Dabrafenib—Insomnia—Allopurinol—gout	0.000188	0.00184	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Indomethacin—gout	0.000187	0.00183	CcSEcCtD
Dabrafenib—Dry mouth—Naproxen—gout	0.000185	0.00181	CcSEcCtD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—SLC17A3—gout	0.000184	0.00249	CbGpPWpGaD
Dabrafenib—SLCO1B3—Transmembrane transport of small molecules—SLC22A12—gout	0.000183	0.00247	CbGpPWpGaD
Dabrafenib—Oedema—Naproxen—gout	0.000181	0.00177	CcSEcCtD
Dabrafenib—Abdominal pain—Indomethacin—gout	0.000181	0.00177	CcSEcCtD
Dabrafenib—Body temperature increased—Indomethacin—gout	0.000181	0.00177	CcSEcCtD
Dabrafenib—Decreased appetite—Allopurinol—gout	0.00018	0.00177	CcSEcCtD
Dabrafenib—Infection—Naproxen—gout	0.00018	0.00176	CcSEcCtD
Dabrafenib—Dry skin—Prednisolone—gout	0.000179	0.00176	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Allopurinol—gout	0.000179	0.00176	CcSEcCtD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—SLC17A1—gout	0.000178	0.00241	CbGpPWpGaD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—SLC22A11—gout	0.000178	0.00241	CbGpPWpGaD
Dabrafenib—BRAF—Corticotropin-releasing hormone—POMC—gout	0.000178	0.00241	CbGpPWpGaD
Dabrafenib—Nervous system disorder—Naproxen—gout	0.000178	0.00174	CcSEcCtD
Dabrafenib—Constipation—Allopurinol—gout	0.000177	0.00174	CcSEcCtD
Dabrafenib—Thrombocytopenia—Naproxen—gout	0.000177	0.00174	CcSEcCtD
Dabrafenib—Hypersensitivity—Colchicine—gout	0.000177	0.00174	CcSEcCtD
Dabrafenib—ABCB1—HIF-1-alpha transcription factor network—ABCG2—gout	0.000177	0.00239	CbGpPWpGaD
Dabrafenib—Skin disorder—Naproxen—gout	0.000176	0.00172	CcSEcCtD
Dabrafenib—Dry skin—Hydrocortisone—gout	0.000175	0.00172	CcSEcCtD
Dabrafenib—Hyperhidrosis—Naproxen—gout	0.000175	0.00172	CcSEcCtD
Dabrafenib—Abdominal pain upper—Hydrocortisone—gout	0.000175	0.00171	CcSEcCtD
Dabrafenib—Hypokalaemia—Hydrocortisone—gout	0.000174	0.0017	CcSEcCtD
Dabrafenib—Asthenia—Colchicine—gout	0.000173	0.00169	CcSEcCtD
Dabrafenib—RAF1—Transmembrane transport of small molecules—SLC22A11—gout	0.000172	0.00233	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—SLC17A1—gout	0.000172	0.00233	CbGpPWpGaD
Dabrafenib—SLCO1B3—Transmembrane transport of small molecules—SLC2A9—gout	0.00017	0.0023	CbGpPWpGaD
Dabrafenib—Gastrointestinal pain—Allopurinol—gout	0.00017	0.00166	CcSEcCtD
Dabrafenib—Hypotension—Naproxen—gout	0.000169	0.00166	CcSEcCtD
Dabrafenib—Alanine aminotransferase increased—Hydrocortisone—gout	0.000169	0.00165	CcSEcCtD
Dabrafenib—Hypersensitivity—Indomethacin—gout	0.000168	0.00165	CcSEcCtD
Dabrafenib—LIMK1—Innate Immune System—CASP1—gout	0.000167	0.00226	CbGpPWpGaD
Dabrafenib—Pancreatitis—Prednisolone—gout	0.000166	0.00163	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Naproxen—gout	0.000165	0.00162	CcSEcCtD
Dabrafenib—Diarrhoea—Colchicine—gout	0.000165	0.00161	CcSEcCtD
Dabrafenib—Asthenia—Indomethacin—gout	0.000164	0.00161	CcSEcCtD
Dabrafenib—Abdominal pain—Allopurinol—gout	0.000164	0.00161	CcSEcCtD
Dabrafenib—Body temperature increased—Allopurinol—gout	0.000164	0.00161	CcSEcCtD
Dabrafenib—Insomnia—Naproxen—gout	0.000164	0.00161	CcSEcCtD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—SLC17A1—gout	0.000162	0.00219	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—SLC22A11—gout	0.000162	0.00219	CbGpPWpGaD
Dabrafenib—Pancreatitis—Hydrocortisone—gout	0.000162	0.00159	CcSEcCtD
Dabrafenib—Pruritus—Indomethacin—gout	0.000162	0.00159	CcSEcCtD
Dabrafenib—SLC22A8—Transmembrane transport of small molecules—SLC22A12—gout	0.000162	0.00219	CbGpPWpGaD
Dabrafenib—Alanine aminotransferase increased—Methylprednisolone—gout	0.000158	0.00155	CcSEcCtD
Dabrafenib—Decreased appetite—Naproxen—gout	0.000157	0.00154	CcSEcCtD
Dabrafenib—Cardiac failure congestive—Prednisone—gout	0.000157	0.00154	CcSEcCtD
Dabrafenib—Diarrhoea—Indomethacin—gout	0.000156	0.00153	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Naproxen—gout	0.000156	0.00153	CcSEcCtD
Dabrafenib—Fatigue—Naproxen—gout	0.000156	0.00153	CcSEcCtD
Dabrafenib—RAF1—MAPK Signaling Pathway—CASP1—gout	0.000155	0.0021	CbGpPWpGaD
Dabrafenib—Constipation—Naproxen—gout	0.000155	0.00152	CcSEcCtD
Dabrafenib—Vomiting—Colchicine—gout	0.000153	0.0015	CcSEcCtD
Dabrafenib—Hypersensitivity—Allopurinol—gout	0.000153	0.0015	CcSEcCtD
Dabrafenib—Pancreatitis—Methylprednisolone—gout	0.000152	0.00149	CcSEcCtD
Dabrafenib—Rash—Colchicine—gout	0.000152	0.00149	CcSEcCtD
Dabrafenib—Dermatitis—Colchicine—gout	0.000152	0.00149	CcSEcCtD
Dabrafenib—Dizziness—Indomethacin—gout	0.000151	0.00148	CcSEcCtD
Dabrafenib—Headache—Colchicine—gout	0.000151	0.00148	CcSEcCtD
Dabrafenib—SLC22A8—Transmembrane transport of small molecules—SLC2A9—gout	0.00015	0.00203	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—SLC22A11—gout	0.00015	0.00203	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—SLC17A1—gout	0.00015	0.00203	CbGpPWpGaD
Dabrafenib—Asthenia—Allopurinol—gout	0.000149	0.00146	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Naproxen—gout	0.000148	0.00145	CcSEcCtD
Dabrafenib—Infestation NOS—Hydrocortisone—gout	0.000147	0.00144	CcSEcCtD
Dabrafenib—Infestation—Hydrocortisone—gout	0.000147	0.00144	CcSEcCtD
Dabrafenib—Pruritus—Allopurinol—gout	0.000147	0.00144	CcSEcCtD
Dabrafenib—Vomiting—Indomethacin—gout	0.000145	0.00142	CcSEcCtD
Dabrafenib—Rash—Indomethacin—gout	0.000144	0.00141	CcSEcCtD
Dabrafenib—Dermatitis—Indomethacin—gout	0.000144	0.00141	CcSEcCtD
Dabrafenib—Headache—Indomethacin—gout	0.000143	0.0014	CcSEcCtD
Dabrafenib—Abdominal pain—Naproxen—gout	0.000143	0.0014	CcSEcCtD
Dabrafenib—Body temperature increased—Naproxen—gout	0.000143	0.0014	CcSEcCtD
Dabrafenib—Nausea—Colchicine—gout	0.000143	0.0014	CcSEcCtD
Dabrafenib—Diarrhoea—Allopurinol—gout	0.000142	0.00139	CcSEcCtD
Dabrafenib—BRAF—Disease—PRPS1—gout	0.000139	0.00188	CbGpPWpGaD
Dabrafenib—BRAF—Disease—PRPS2—gout	0.000139	0.00188	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—BCKDHA—gout	0.000139	0.00187	CbGpPWpGaD
Dabrafenib—Infestation NOS—Methylprednisolone—gout	0.000138	0.00136	CcSEcCtD
Dabrafenib—Infestation—Methylprednisolone—gout	0.000138	0.00136	CcSEcCtD
Dabrafenib—Dizziness—Allopurinol—gout	0.000137	0.00134	CcSEcCtD
Dabrafenib—Haemoglobin—Prednisolone—gout	0.000136	0.00133	CcSEcCtD
Dabrafenib—Nausea—Indomethacin—gout	0.000136	0.00133	CcSEcCtD
Dabrafenib—Haemorrhage—Prednisolone—gout	0.000135	0.00133	CcSEcCtD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—SLC22A12—gout	0.000135	0.00183	CbGpPWpGaD
Dabrafenib—Hypersensitivity—Naproxen—gout	0.000133	0.00131	CcSEcCtD
Dabrafenib—Haemoglobin—Hydrocortisone—gout	0.000133	0.0013	CcSEcCtD
Dabrafenib—Haemorrhage—Hydrocortisone—gout	0.000132	0.0013	CcSEcCtD
Dabrafenib—Vomiting—Allopurinol—gout	0.000132	0.00129	CcSEcCtD
Dabrafenib—Rash—Allopurinol—gout	0.000131	0.00128	CcSEcCtD
Dabrafenib—Dermatitis—Allopurinol—gout	0.000131	0.00128	CcSEcCtD
Dabrafenib—Dry skin—Prednisone—gout	0.00013	0.00128	CcSEcCtD
Dabrafenib—RAF1—Transmembrane transport of small molecules—SLC22A12—gout	0.00013	0.00176	CbGpPWpGaD
Dabrafenib—Headache—Allopurinol—gout	0.00013	0.00127	CcSEcCtD
Dabrafenib—Asthenia—Naproxen—gout	0.00013	0.00127	CcSEcCtD
Dabrafenib—Connective tissue disorder—Hydrocortisone—gout	0.00013	0.00127	CcSEcCtD
Dabrafenib—Hypokalaemia—Prednisone—gout	0.000129	0.00127	CcSEcCtD
Dabrafenib—Pruritus—Naproxen—gout	0.000128	0.00126	CcSEcCtD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—SLC2A9—gout	0.000125	0.0017	CbGpPWpGaD
Dabrafenib—Alanine aminotransferase increased—Prednisone—gout	0.000125	0.00123	CcSEcCtD
Dabrafenib—Haemoglobin—Methylprednisolone—gout	0.000125	0.00122	CcSEcCtD
Dabrafenib—Haemorrhage—Methylprednisolone—gout	0.000124	0.00122	CcSEcCtD
Dabrafenib—Diarrhoea—Naproxen—gout	0.000124	0.00121	CcSEcCtD
Dabrafenib—Eye disorder—Hydrocortisone—gout	0.000124	0.00121	CcSEcCtD
Dabrafenib—Nausea—Allopurinol—gout	0.000123	0.00121	CcSEcCtD
Dabrafenib—RAF1—Corticotropin-releasing hormone—POMC—gout	0.000123	0.00167	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—SLC22A12—gout	0.000123	0.00166	CbGpPWpGaD
Dabrafenib—Connective tissue disorder—Methylprednisolone—gout	0.000122	0.0012	CcSEcCtD
Dabrafenib—RAF1—Transmembrane transport of small molecules—SLC2A9—gout	0.000121	0.00164	CbGpPWpGaD
Dabrafenib—Arrhythmia—Prednisolone—gout	0.000121	0.00119	CcSEcCtD
Dabrafenib—Pancreatitis—Prednisone—gout	0.000121	0.00118	CcSEcCtD
Dabrafenib—Dizziness—Naproxen—gout	0.00012	0.00117	CcSEcCtD
Dabrafenib—Immune system disorder—Hydrocortisone—gout	0.000119	0.00117	CcSEcCtD
Dabrafenib—RAF1—Innate Immune System—NLRP3—gout	0.000119	0.0016	CbGpPWpGaD
Dabrafenib—Arrhythmia—Hydrocortisone—gout	0.000118	0.00116	CcSEcCtD
Dabrafenib—Erythema—Prednisolone—gout	0.000118	0.00115	CcSEcCtD
Dabrafenib—Eye disorder—Methylprednisolone—gout	0.000116	0.00114	CcSEcCtD
Dabrafenib—Mental disorder—Hydrocortisone—gout	0.000116	0.00114	CcSEcCtD
Dabrafenib—Vomiting—Naproxen—gout	0.000115	0.00113	CcSEcCtD
Dabrafenib—Malnutrition—Hydrocortisone—gout	0.000115	0.00113	CcSEcCtD
Dabrafenib—Erythema—Hydrocortisone—gout	0.000115	0.00113	CcSEcCtD
Dabrafenib—Neutropenia—Prednisone—gout	0.000115	0.00113	CcSEcCtD
Dabrafenib—Rash—Naproxen—gout	0.000114	0.00112	CcSEcCtD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—SLC2A9—gout	0.000114	0.00154	CbGpPWpGaD
Dabrafenib—Dermatitis—Naproxen—gout	0.000114	0.00112	CcSEcCtD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—SLC22A12—gout	0.000114	0.00154	CbGpPWpGaD
Dabrafenib—Headache—Naproxen—gout	0.000113	0.00111	CcSEcCtD
Dabrafenib—SLCO1B3—Metabolism—PRPS2—gout	0.000113	0.00153	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—HPRT1—gout	0.000113	0.00153	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PRPS1—gout	0.000113	0.00153	CbGpPWpGaD
Dabrafenib—Angiopathy—Methylprednisolone—gout	0.000113	0.0011	CcSEcCtD
Dabrafenib—Immune system disorder—Methylprednisolone—gout	0.000112	0.0011	CcSEcCtD
Dabrafenib—Mediastinal disorder—Methylprednisolone—gout	0.000112	0.0011	CcSEcCtD
Dabrafenib—Vision blurred—Prednisolone—gout	0.000111	0.00109	CcSEcCtD
Dabrafenib—Arrhythmia—Methylprednisolone—gout	0.000111	0.00109	CcSEcCtD
Dabrafenib—Hyperglycaemia—Prednisone—gout	0.000111	0.00109	CcSEcCtD
Dabrafenib—Mental disorder—Methylprednisolone—gout	0.000109	0.00107	CcSEcCtD
Dabrafenib—Malnutrition—Methylprednisolone—gout	0.000108	0.00106	CcSEcCtD
Dabrafenib—Erythema—Methylprednisolone—gout	0.000108	0.00106	CcSEcCtD
Dabrafenib—Nausea—Naproxen—gout	0.000108	0.00105	CcSEcCtD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—SLC2A9—gout	0.000106	0.00143	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—CASP1—gout	0.000103	0.0014	CbGpPWpGaD
Dabrafenib—Hypertension—Prednisolone—gout	0.000102	0.000997	CcSEcCtD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—IL1RN—gout	0.0001	0.00135	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—SLC17A3—gout	9.95e-05	0.00135	CbGpPWpGaD
Dabrafenib—Hypertension—Hydrocortisone—gout	9.94e-05	0.000974	CcSEcCtD
Dabrafenib—Haemoglobin—Prednisone—gout	9.89e-05	0.000969	CcSEcCtD
Dabrafenib—Haemorrhage—Prednisone—gout	9.84e-05	0.000964	CcSEcCtD
Dabrafenib—Myalgia—Hydrocortisone—gout	9.8e-05	0.00096	CcSEcCtD
Dabrafenib—LIMK1—Immune System—CASP1—gout	9.75e-05	0.00132	CbGpPWpGaD
Dabrafenib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—gout	9.73e-05	0.000954	CcSEcCtD
Dabrafenib—Connective tissue disorder—Prednisone—gout	9.67e-05	0.000947	CcSEcCtD
Dabrafenib—Oedema—Prednisolone—gout	9.62e-05	0.000943	CcSEcCtD
Dabrafenib—RAF1—Disease—PRPS1—gout	9.62e-05	0.0013	CbGpPWpGaD
Dabrafenib—RAF1—Disease—PRPS2—gout	9.62e-05	0.0013	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—IL1RN—gout	9.44e-05	0.00128	CbGpPWpGaD
Dabrafenib—Oedema—Hydrocortisone—gout	9.4e-05	0.000921	CcSEcCtD
Dabrafenib—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—gout	9.39e-05	0.00127	CbGpPWpGaD
Dabrafenib—Hypertension—Methylprednisolone—gout	9.34e-05	0.000915	CcSEcCtD
Dabrafenib—Infection—Hydrocortisone—gout	9.34e-05	0.000915	CcSEcCtD
Dabrafenib—SLCO1B1—Metabolism—BCKDHA—gout	9.31e-05	0.00126	CbGpPWpGaD
Dabrafenib—Hyperhidrosis—Prednisolone—gout	9.3e-05	0.000911	CcSEcCtD
Dabrafenib—Nervous system disorder—Hydrocortisone—gout	9.22e-05	0.000903	CcSEcCtD
Dabrafenib—Myalgia—Methylprednisolone—gout	9.21e-05	0.000902	CcSEcCtD
Dabrafenib—Arthralgia—Methylprednisolone—gout	9.21e-05	0.000902	CcSEcCtD
Dabrafenib—Eye disorder—Prednisone—gout	9.2e-05	0.000901	CcSEcCtD
Dabrafenib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—gout	9.15e-05	0.000896	CcSEcCtD
Dabrafenib—Skin disorder—Hydrocortisone—gout	9.13e-05	0.000894	CcSEcCtD
Dabrafenib—Hyperhidrosis—Hydrocortisone—gout	9.08e-05	0.00089	CcSEcCtD
Dabrafenib—Angiopathy—Prednisone—gout	8.93e-05	0.000875	CcSEcCtD
Dabrafenib—SLCO1B3—Transmembrane transport of small molecules—ABCG2—gout	8.93e-05	0.00121	CbGpPWpGaD
Dabrafenib—Immune system disorder—Prednisone—gout	8.89e-05	0.000871	CcSEcCtD
Dabrafenib—Arrhythmia—Prednisone—gout	8.79e-05	0.000861	CcSEcCtD
Dabrafenib—Hypotension—Hydrocortisone—gout	8.78e-05	0.00086	CcSEcCtD
Dabrafenib—Infection—Methylprednisolone—gout	8.77e-05	0.000859	CcSEcCtD
Dabrafenib—Insomnia—Prednisolone—gout	8.7e-05	0.000853	CcSEcCtD
Dabrafenib—Alopecia—Prednisone—gout	8.7e-05	0.000852	CcSEcCtD
Dabrafenib—Nervous system disorder—Methylprednisolone—gout	8.66e-05	0.000848	CcSEcCtD
Dabrafenib—Mental disorder—Prednisone—gout	8.62e-05	0.000845	CcSEcCtD
Dabrafenib—ABCG2—Metabolism—BCKDHA—gout	8.62e-05	0.00117	CbGpPWpGaD
Dabrafenib—Skin disorder—Methylprednisolone—gout	8.58e-05	0.00084	CcSEcCtD
Dabrafenib—Erythema—Prednisone—gout	8.57e-05	0.000839	CcSEcCtD
Dabrafenib—Malnutrition—Prednisone—gout	8.57e-05	0.000839	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Hydrocortisone—gout	8.56e-05	0.000839	CcSEcCtD
Dabrafenib—Hyperhidrosis—Methylprednisolone—gout	8.53e-05	0.000836	CcSEcCtD
Dabrafenib—Insomnia—Hydrocortisone—gout	8.5e-05	0.000833	CcSEcCtD
Dabrafenib—Hypotension—Methylprednisolone—gout	8.25e-05	0.000808	CcSEcCtD
Dabrafenib—Decreased appetite—Hydrocortisone—gout	8.17e-05	0.0008	CcSEcCtD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—SLC17A1—gout	8.11e-05	0.0011	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—SLC22A11—gout	8.11e-05	0.0011	CbGpPWpGaD
Dabrafenib—Gastrointestinal disorder—Hydrocortisone—gout	8.11e-05	0.000795	CcSEcCtD
Dabrafenib—Fatigue—Hydrocortisone—gout	8.1e-05	0.000794	CcSEcCtD
Dabrafenib—Vision blurred—Prednisone—gout	8.07e-05	0.000791	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Methylprednisolone—gout	8.04e-05	0.000788	CcSEcCtD
Dabrafenib—Insomnia—Methylprednisolone—gout	7.98e-05	0.000782	CcSEcCtD
Dabrafenib—Anaemia—Prednisone—gout	7.92e-05	0.000776	CcSEcCtD
Dabrafenib—SLC22A8—Transmembrane transport of small molecules—ABCG2—gout	7.9e-05	0.00107	CbGpPWpGaD
Dabrafenib—Gastrointestinal pain—Hydrocortisone—gout	7.68e-05	0.000753	CcSEcCtD
Dabrafenib—Fatigue—Methylprednisolone—gout	7.61e-05	0.000746	CcSEcCtD
Dabrafenib—CYP2C8—Phase 1 - Functionalization of compounds—POMC—gout	7.61e-05	0.00103	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PRPS2—gout	7.59e-05	0.00103	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PRPS1—gout	7.59e-05	0.00103	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—HPRT1—gout	7.59e-05	0.00103	CbGpPWpGaD
Dabrafenib—Abdominal pain—Hydrocortisone—gout	7.43e-05	0.000728	CcSEcCtD
Dabrafenib—Body temperature increased—Hydrocortisone—gout	7.43e-05	0.000728	CcSEcCtD
Dabrafenib—Hypertension—Prednisone—gout	7.4e-05	0.000725	CcSEcCtD
Dabrafenib—Arthralgia—Prednisone—gout	7.29e-05	0.000714	CcSEcCtD
Dabrafenib—Myalgia—Prednisone—gout	7.29e-05	0.000714	CcSEcCtD
Dabrafenib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—gout	7.24e-05	0.00071	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Methylprednisolone—gout	7.22e-05	0.000707	CcSEcCtD
Dabrafenib—Hypersensitivity—Prednisolone—gout	7.09e-05	0.000694	CcSEcCtD
Dabrafenib—ABCG2—Metabolism—PRPS1—gout	7.03e-05	0.000951	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—HPRT1—gout	7.03e-05	0.000951	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PRPS2—gout	7.03e-05	0.000951	CbGpPWpGaD
Dabrafenib—Oedema—Prednisone—gout	6.99e-05	0.000685	CcSEcCtD
Dabrafenib—Abdominal pain—Methylprednisolone—gout	6.98e-05	0.000684	CcSEcCtD
Dabrafenib—Infection—Prednisone—gout	6.95e-05	0.00068	CcSEcCtD
Dabrafenib—Hypersensitivity—Hydrocortisone—gout	6.92e-05	0.000678	CcSEcCtD
Dabrafenib—RAF1—Immune System—NLRP3—gout	6.9e-05	0.000934	CbGpPWpGaD
Dabrafenib—Nervous system disorder—Prednisone—gout	6.86e-05	0.000672	CcSEcCtD
Dabrafenib—Skin disorder—Prednisone—gout	6.79e-05	0.000665	CcSEcCtD
Dabrafenib—Hyperhidrosis—Prednisone—gout	6.76e-05	0.000662	CcSEcCtD
Dabrafenib—Asthenia—Hydrocortisone—gout	6.74e-05	0.00066	CcSEcCtD
Dabrafenib—Pruritus—Hydrocortisone—gout	6.65e-05	0.000651	CcSEcCtD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—ABCG2—gout	6.59e-05	0.000892	CbGpPWpGaD
Dabrafenib—Hypersensitivity—Methylprednisolone—gout	6.5e-05	0.000637	CcSEcCtD
Dabrafenib—Diarrhoea—Hydrocortisone—gout	6.43e-05	0.00063	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Prednisone—gout	6.37e-05	0.000624	CcSEcCtD
Dabrafenib—RAF1—Transmembrane transport of small molecules—ABCG2—gout	6.37e-05	0.000861	CbGpPWpGaD
Dabrafenib—Dizziness—Prednisolone—gout	6.36e-05	0.000623	CcSEcCtD
Dabrafenib—Asthenia—Methylprednisolone—gout	6.33e-05	0.000621	CcSEcCtD
Dabrafenib—Insomnia—Prednisone—gout	6.32e-05	0.000619	CcSEcCtD
Dabrafenib—Pruritus—Methylprednisolone—gout	6.25e-05	0.000612	CcSEcCtD
Dabrafenib—Dizziness—Hydrocortisone—gout	6.21e-05	0.000609	CcSEcCtD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—SLC22A12—gout	6.15e-05	0.000832	CbGpPWpGaD
Dabrafenib—Decreased appetite—Prednisone—gout	6.08e-05	0.000595	CcSEcCtD
Dabrafenib—Rash—Prednisolone—gout	6.07e-05	0.000594	CcSEcCtD
Dabrafenib—Dermatitis—Prednisolone—gout	6.06e-05	0.000594	CcSEcCtD
Dabrafenib—Diarrhoea—Methylprednisolone—gout	6.04e-05	0.000592	CcSEcCtD
Dabrafenib—Fatigue—Prednisone—gout	6.03e-05	0.000591	CcSEcCtD
Dabrafenib—Headache—Prednisolone—gout	6.03e-05	0.00059	CcSEcCtD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—ABCG2—gout	6e-05	0.000811	CbGpPWpGaD
Dabrafenib—Constipation—Prednisone—gout	5.98e-05	0.000586	CcSEcCtD
Dabrafenib—Vomiting—Hydrocortisone—gout	5.97e-05	0.000585	CcSEcCtD
Dabrafenib—Rash—Hydrocortisone—gout	5.92e-05	0.00058	CcSEcCtD
Dabrafenib—Dermatitis—Hydrocortisone—gout	5.92e-05	0.00058	CcSEcCtD
Dabrafenib—Headache—Hydrocortisone—gout	5.89e-05	0.000577	CcSEcCtD
Dabrafenib—Dizziness—Methylprednisolone—gout	5.84e-05	0.000572	CcSEcCtD
Dabrafenib—RAF1—Innate Immune System—CASP1—gout	5.79e-05	0.000783	CbGpPWpGaD
Dabrafenib—Gastrointestinal pain—Prednisone—gout	5.72e-05	0.00056	CcSEcCtD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—SLC2A9—gout	5.72e-05	0.000773	CbGpPWpGaD
Dabrafenib—Nausea—Prednisolone—gout	5.71e-05	0.00056	CcSEcCtD
Dabrafenib—Vomiting—Methylprednisolone—gout	5.61e-05	0.00055	CcSEcCtD
Dabrafenib—Nausea—Hydrocortisone—gout	5.58e-05	0.000547	CcSEcCtD
Dabrafenib—Rash—Methylprednisolone—gout	5.57e-05	0.000545	CcSEcCtD
Dabrafenib—Dermatitis—Methylprednisolone—gout	5.56e-05	0.000545	CcSEcCtD
Dabrafenib—Headache—Methylprednisolone—gout	5.53e-05	0.000542	CcSEcCtD
Dabrafenib—Body temperature increased—Prednisone—gout	5.53e-05	0.000541	CcSEcCtD
Dabrafenib—Abdominal pain—Prednisone—gout	5.53e-05	0.000541	CcSEcCtD
Dabrafenib—CYP2C8—Metabolism—BCKDHA—gout	5.35e-05	0.000724	CbGpPWpGaD
Dabrafenib—Nausea—Methylprednisolone—gout	5.24e-05	0.000514	CcSEcCtD
Dabrafenib—Hypersensitivity—Prednisone—gout	5.15e-05	0.000505	CcSEcCtD
Dabrafenib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—gout	5.04e-05	0.000682	CbGpPWpGaD
Dabrafenib—Asthenia—Prednisone—gout	5.02e-05	0.000491	CcSEcCtD
Dabrafenib—Pruritus—Prednisone—gout	4.95e-05	0.000485	CcSEcCtD
Dabrafenib—Diarrhoea—Prednisone—gout	4.78e-05	0.000469	CcSEcCtD
Dabrafenib—ABCB1—Metabolism—BCKDHA—gout	4.66e-05	0.000631	CbGpPWpGaD
Dabrafenib—Dizziness—Prednisone—gout	4.62e-05	0.000453	CcSEcCtD
Dabrafenib—Vomiting—Prednisone—gout	4.45e-05	0.000435	CcSEcCtD
Dabrafenib—Rash—Prednisone—gout	4.41e-05	0.000432	CcSEcCtD
Dabrafenib—Dermatitis—Prednisone—gout	4.4e-05	0.000431	CcSEcCtD
Dabrafenib—Headache—Prednisone—gout	4.38e-05	0.000429	CcSEcCtD
Dabrafenib—CYP2C8—Metabolism—PRPS2—gout	4.36e-05	0.00059	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PRPS1—gout	4.36e-05	0.00059	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—HPRT1—gout	4.36e-05	0.00059	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—ABCG2—gout	4.18e-05	0.000566	CbGpPWpGaD
Dabrafenib—Nausea—Prednisone—gout	4.15e-05	0.000407	CcSEcCtD
Dabrafenib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—gout	4.08e-05	0.000553	CbGpPWpGaD
Dabrafenib—CYP2C8—Biological oxidations—POMC—gout	4.04e-05	0.000547	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—gout	4.02e-05	0.000544	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—HPRT1—gout	3.8e-05	0.000514	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PRPS2—gout	3.8e-05	0.000514	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PRPS1—gout	3.8e-05	0.000514	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CASP1—gout	3.37e-05	0.000456	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL1RN—gout	3.26e-05	0.000442	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—ABCG2—gout	3e-05	0.000406	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—BCKDHA—gout	2.87e-05	0.000388	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ABCG2—gout	2.81e-05	0.00038	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—gout	2.7e-05	0.000365	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—HPRT1—gout	2.34e-05	0.000317	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PRPS2—gout	2.34e-05	0.000317	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PRPS1—gout	2.34e-05	0.000317	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—POMC—gout	2.17e-05	0.000293	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—POMC—gout	1.81e-05	0.000245	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—POMC—gout	1.79e-05	0.000242	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ABCG2—gout	1.61e-05	0.000218	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—gout	1.55e-05	0.00021	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—POMC—gout	1.54e-05	0.000209	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ABCG2—gout	1.41e-05	0.00019	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—POMC—gout	1.2e-05	0.000163	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—POMC—gout	1.11e-05	0.000151	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—POMC—gout	1.07e-05	0.000144	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ABCG2—gout	8.66e-06	0.000117	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—POMC—gout	6.91e-06	9.35e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—POMC—gout	6.02e-06	8.15e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—POMC—gout	3.71e-06	5.02e-05	CbGpPWpGaD
